MarketBeat
05 Nov 2026, 05:31 UTC · 1w ago
Progyny Q3 Earnings Call Highlights
Impact · against what's priced in
Progyny's record client wins and raised FY2026 guidance provide a positive catalyst for growth expectations heading into 2027. The significant addition of 1.3 million covered lives creates a clear revenue tailwind that likely exceeds current market assumptions for the next fiscal year.
- PGNY+0.70
No priced-in read yet
- In context
The company raised its FY2026 revenue guidance midpoint and secured a record 1.3 million new covered lives, most of which launch in Q1 2027, providing significant visibility into future growth.
Read from the article alone

Search tags




